These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23880676)

  • 1. Rare diseases research: expanding collaborative translational research opportunities.
    Groft SC
    Chest; 2013 Jul; 144(1):16-23. PubMed ID: 23880676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New and evolving rare diseases research programs at the National Institutes of Health.
    Groft SC; Rubinstein YR
    Public Health Genomics; 2013; 16(6):259-67. PubMed ID: 24503586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data.
    Groft SC; Posada de la Paz M
    Adv Exp Med Biol; 2017; 1031():3-21. PubMed ID: 29214563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advocacy groups and their role in rare diseases research.
    Dunkle M; Pines W; Saltonstall PL
    Adv Exp Med Biol; 2010; 686():515-25. PubMed ID: 20824463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New NIH center broadens scope of translational research.
    Jenks S
    J Natl Cancer Inst; 2012 May; 104(10):728-31. PubMed ID: 22544941
    [No Abstract]   [Full Text] [Related]  

  • 6. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
    Chung TD
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A past with uncertainty, a future with hope--rare disease day 2014 from a USA perspective.
    Groft SC
    Orphanet J Rare Dis; 2014 Feb; 9():31. PubMed ID: 24580809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012.
    O'Reilly M; Kohn DB; Bartlett J; Benson J; Brooks PJ; Byrne BJ; Camozzi C; Cornetta K; Crystal RG; Fong Y; Gargiulo L; Gopal-Srivastava R; High KA; Jacobson SG; Jambou RC; Montgomery M; Rosenthal E; Samulski RJ; Skarlatos SI; Sorrentino B; Wilson JM; Xie Y; Corrigan-Curay J
    Hum Gene Ther; 2013 Apr; 24(4):355-62. PubMed ID: 23517518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of research collaborations and consortia in rare cancers.
    Blay JY; Coindre JM; Ducimetière F; Ray-Coquard I
    Lancet Oncol; 2016 Feb; 17(2):e62-e69. PubMed ID: 26868355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding research to provide an evidence base for nutritional interventions for the management of inborn errors of metabolism.
    Camp KM; Lloyd-Puryear MA; Yao L; Groft SC; Parisi MA; Mulberg A; Gopal-Srivastava R; Cederbaum S; Enns GM; Ershow AG; Frazier DM; Gohagan J; Harding C; Howell RR; Regan K; Stacpoole PW; Venditti C; Vockley J; Watson M; Coates PM
    Mol Genet Metab; 2013 Aug; 109(4):319-28. PubMed ID: 23806236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An NIH intramural percubator as a model of academic-industry partnerships: from the beginning of life through the valley of death.
    Emmert-Buck MR
    J Transl Med; 2011 May; 9():54. PubMed ID: 21548992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The path to personalized medicine.
    Hamburg MA; Collins FS
    N Engl J Med; 2010 Jul; 363(4):301-4. PubMed ID: 20551152
    [No Abstract]   [Full Text] [Related]  

  • 13. A call to study orphan diseases.
    Alawi F
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Aug; 126(2):95-97. PubMed ID: 29861184
    [No Abstract]   [Full Text] [Related]  

  • 14. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical research for rare disease: opportunities, challenges, and solutions.
    Griggs RC; Batshaw M; Dunkle M; Gopal-Srivastava R; Kaye E; Krischer J; Nguyen T; Paulus K; Merkel PA;
    Mol Genet Metab; 2009 Jan; 96(1):20-6. PubMed ID: 19013090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An NIH National Center for Advancing Translational Sciences: is a focus on drug discovery the best option?
    Littman BH
    Nat Rev Drug Discov; 2011 Jun; 10(6):471. PubMed ID: 21597471
    [No Abstract]   [Full Text] [Related]  

  • 17. NIH TRND program: successes in preclinical therapeutic development.
    McKew JC; Pilon AM
    Trends Pharmacol Sci; 2013 Feb; 34(2):87-9. PubMed ID: 23174531
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS).
    ; Shamoon H; Center D; Davis P; Tuchman M; Ginsberg H; Califf R; Stephens D; Mellman T; Verbalis J; Nadler L; Shekhar A; Ford D; Rizza R; Shaker R; Brady K; Murphy B; Cronstein B; Hochman J; Greenland P; Orwoll E; Sinoway L; Greenberg H; Jackson R; Coller B; Topol E; Guay-Woodford L; Runge M; Clark R; McClain D; Selker H; Lowery C; Dubinett S; Berglund L; Cooper D; Firestein G; Johnston SC; Solway J; Heubi J; Sokol R; Nelson D; Tobacman L; Rosenthal G; Aaronson L; Barohn R; Kern P; Sullivan J; Shanley T; Blazar B; Larson R; FitzGerald G; Reis S; Pearson T; Buchanan T; McPherson D; Brasier A; Toto R; Disis M; Drezner M; Bernard G; Clore J; Evanoff B; Imperato-McGinley J; Sherwin R; Pulley J
    Clin Transl Sci; 2012 Apr; 5(2):121-9. PubMed ID: 22507116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparing for the Future of Rare Diseases.
    Groft SC; Posada de la Paz M
    Adv Exp Med Biol; 2017; 1031():641-648. PubMed ID: 29214596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Working with the CTSA Consortium: what we bring to the table.
    Steele SJ
    Sci Transl Med; 2010 Dec; 2(63):63mr5. PubMed ID: 21178135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.